Clinical trial
The Clinical Response Evaluation of the Medtronic Endeavor CR ABT-578 Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions
NCT00248079 is registered in ClinicalTrials.gov with Medtronic Vascular as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Clinical Response Evaluation of the Medtronic Endeavor CR ABT-578 Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions
- Lead sponsor
- Medtronic Vascular
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- November 30, 2005
- Completion date
- October 31, 2011
- Enrollment
- 139 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.